Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors

American Journal of Surgical Pathology

Volumn 36, Issue 2, 2012, Pages 173-184

  Yachida, Shinichi ^a   Vakiani, Efsevia ^a   White, Catherine M ^a   Zhong, Yi ^a   Saunders, Tyler ^a   Morgan, Richard ^a   De Wilde, Roeland F ^a   Maitra, Anirban ^a   Hicks, Jessica ^a   DeMarzo, Angelo M ^a   Shi, Chanjuan ^b   Sharma, Rajni ^a   Laheru, Daniel ^a   Edil, Barish H ^c   Wolfgang, Christopher L ^c   Schulick, Richard D ^c   Hruban, Ralph H ^a   Tang, Laura H ^a   Klimstra, David S ^a   Iacobuzio Donahue, Christine A ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Mutation; Neuroendocrine carcinoma; Pancreatic ductal adenocarcinoma; RB1; TP53

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOMA; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; MALE; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; SMALL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SMALL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS;

EID: 84857714411     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182417d36     Document Type: Article

References (56)

1. Atasoy P, Bozdogan O, Ozturk S, et al. Bcl2 expression and its correlation with neuroendocrine differentiation in colon carcinomas. Tumori. 2004;90:233-238. (Pubitemid 38745614)
2. Baas IO, Mulder JW, Offerhaus GJ, et al. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol. 1994;172:5-12. (Pubitemid 24074995)
3. Barton CM, McKie AB, Hogg A, et al. Abnormalities of the RB1 and DCC tumor suppressor genes: uncommon in human pancreatic adenocarcinoma. Mol Carcinog. 1995;13:61-69.
4. Bosman FT, Carneiro F, Hruban RH, et al. WHO Classification of Tumours of the Digestive System. Lyon: International Agency for Research on Cancer (IARC); 2010.
5. Brennan SM, Gregory DL, Stillie A, et al. Should extrapulmonary small cell cancer be managed like small cell lung cancer? Cancer. 2010;116:888-895.
6. Cagle PT, el-Naggar AK, Xu HJ, et al. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications. Am J Pathol. 1997;150:393-400. (Pubitemid 27073768)
7. Chung MS, Ha TK, Lee KG, et al. A case of long survival in poorly differentiated small cell carcinoma of the pancreas. World J Gastroenterol. 2008;14:4964-4967.
8. Delle Fave G, Corleto VD. Oncogenes, growth factors, receptor expression and proliferation markers in digestive neuroendocrine tumours. A critical reappraisal. Ann Oncol. 2001;12(suppl 2):S13-S17. (Pubitemid 33069681)
9. Ekeblad S, Skogseid B, Dunder K, et al. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res. 2008;14:7798-7803.
10. El Maalouf G, Rodier JM, Faivre S, et al. Could we expect to improve survival in small cell lung cancer? Lung Cancer. 2007; 57(suppl 2):S30-S34. (Pubitemid 47188080)
11. Finkelstein SD, Przygodzki R, Pricolo VE, et al. K-ras-2 topographic genotyping of pancreatic adenocarcinoma. Arch Surg. 1994;129:367-372; discussion 372-373.
12. Fisher TC, Milner AE, Gregory CD, et al. bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res. 1993;53:3321-3326. (Pubitemid 23223304)
13. Gao N, LeLay J, Vatamaniuk MZ, et al. Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. Genes Dev. 2008;22:3435-3448.
14. Gerdes B, Ramaswamy A, Ziegler A, et al. p16INK4a is a prognostic marker in resected ductal pancreatic cancer: An analysis of p16INK4a, p53, MDM2, an Rb. Ann Surg. 2002;235:51-59. (Pubitemid 34062399)
15. Hezel AF, Kimmelman AC, Stanger BZ, et al. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006;20: 1218-1249. (Pubitemid 43727584)
16. Hruban RH, Goggins M, Parsons J, et al. Progression model for pancreatic cancer. Clin Cancer Res. 2000;6:2969-2972. (Pubitemid 30637716)
17. Hruban RH, Pitman MB, Klimstra DS. Tumors of the Pancreas. Washington, DC: American Registry of Pathology; 2007.
18. Iacobuzio-Donahue CA, Fu B, Yachida S, et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol. 2009;27:1806-1813.
19. Iwasa S, Morizane C, Okusaka T, et al. Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas. Jpn J Clin Oncol. 2010;40:313-318.
20. Jiang SX, Kameya T, Sato Y, et al. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation. Am J Pathol. 1996;148:837-846. (Pubitemid 126660675)
21. Jiao Y, Shi C, Edil BH, et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011;331:1199-1203.
22. Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res. 2009;15:1126-1132.
23. Kaufmann SH, Gores GJ. Apoptosis in cancer: cause and cure. Bioessays. 2000;22:1007-1017.
24. Kaye FJ. RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer. Oncogene. 2002;21:6908-6914. (Pubitemid 35221937)
25. Kinoshita K, Minami T, Ohmori Y, et al. Curative resection of a small cell carcinoma of the pancreas: report of a case of long survival without chemotherapy. J Gastroenterol Hepatol. 2004;19: 1087-1091. (Pubitemid 39237450)
26. Kitamura H, Yazawa T, Sato H, et al. Small cell lung cancer: significance of RB alterations and TTF-1 expression in its carcinogenesis, phenotype, and biology. Endocr Pathol. 2009;20:101-107.
27. Klimstra DS, Modlin IR, Coppola D, et al. The pathologic classification of neuroendocrine tumors: A review of nomenclature, grading, and staging systems. Pancreas. 2010;39:707-712.
28. Kloppel G, Rindi G, Perren A, et al. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: A statement. Virchows Arch. 2010; 456:595-597.
29. Kouvaraki MA, Solorzano CC, Shapiro SE, et al. Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol. 2005;89:170-185. (Pubitemid 40315914)
30. Lara PN Jr., Natale R, Crowley J, et al. Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage smallcell lung cancer: clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol. 2009;27:2530-2535.
31. Long KB, Srivastava A, Hirsch MS, et al. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors. Am J Surg Pathol. 2010;34: 723-729.
32. Melhem MF, Law JC, el-Ashmawy L, et al. Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers. Am J Pathol. 1995;146: 1170-1177.
33. Meuwissen R, Linn SC, Linnoila RI, et al. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell. 2003;4:181-189. (Pubitemid 37163832)
34. Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell. 2002;1:49-52. (Pubitemid 41039175)
35. Motojima K, Furui J, Terada M, et al. Small cell carcinoma of the pancreas and biliary tract. J Surg Oncol. 1990;45:164-168. (Pubitemid 20382890)
36. Movahedi-Lankarani S, Hruban RH, Westra WH, et al. Primitive neuroectodermal tumors of the pancreas: A report of seven cases of a rare neoplasm. Am J Surg Pathol. 2002;26:1040-1047. (Pubitemid 34810565)
37. Nagatake M, Takagi Y, Osada H, et al. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res. 1996;56:2718-2720. (Pubitemid 26175725)
38. Nassar H, Albores-Saavedra J, Klimstra DS. High-grade neuroendocrine carcinoma of the ampulla of vater: A clinicopathologic and immunohistochemical analysis of 14 cases. Am J Surg Pathol. 2005;29:588-594. (Pubitemid 40577867)
39. Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med. 2002;346:85-91. (Pubitemid 34438898)
40. Obata A, Eura M, Sasaki J, et al. Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx. Int J Cancer. 2000;89:187-193. (Pubitemid 30185929)
41. Ohtani N, Yamakoshi K, Takahashi A, et al. The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. J Med Invest. 2004;51:146-153. (Pubitemid 39610908)
42. Oliver-Krasinski JM, Kasner MT, Yang J, et al. The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in mice. J Clin Invest. 2009;119:1888-1898.
43. Ordonez NG, Cleary KR, Mackay B. Small cell undifferentiated carcinoma of the pancreas. Ultrastruct Pathol. 1997;21:467-474. (Pubitemid 27376672)
44. Paik PK, Rudin CM, Brown A, et al. A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies. Cancer Chemother Pharmacol. 2010;66:1079-1085.
45. Park JY, Hong SM, Klimstra DS, et al. Pdx1 expression in pancreatic precursor lesions and neoplasms. Appl Immunohistochem Mol Morphol. 2011;19:444-449.
46. Parwani AV, Geradts J, Caspers E, et al. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Mod Pathol. 2003;16: 299-308. (Pubitemid 36443978)
47. Reyes CV, Wang T. Undifferentiated small cell carcinoma of the pancreas: A report of five cases. Cancer. 1981;47:2500-2502. (Pubitemid 11127645)
48. Sangoi AR, Ohgami RS, Pai RK, et al. PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma. Mod Pathol. 2011;24: 412-424.
49. Sartorius UA, Krammer PH. Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines. Int J Cancer. 2002;97:584-592. (Pubitemid 34087795)
50. Sjogren S, Inganas M, Norberg T, et al. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst. 1996;88:173-182. (Pubitemid 26065829)
51. Travis WD, Brambilla E, Muller-Hermelink HK, et al. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2004.
52. Wikenheiser-Brokamp KA. Rb family proteins differentially regulate distinct cell lineages during epithelial development. Development. 2004;131:4299-4310. (Pubitemid 39294527)
53. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010;467: 1114-1117.
54. Yachida S, Zhong Y, Patrascu R, et al. Establishment and characterization of a new cell Line, A99, from a primary small cell carcinoma of the pancreas. Pancreas. 2011;40:905-910.
55. Yao JC, Hassan M, Phan A, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063-3072.
56. Zhou XP, Loukola A, Salovaara R, et al. PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers. Am J Pathol. 2002;161: 439-447. (Pubitemid 36142153)